You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 722 Inhibition of integrin avß8-Mediated TGF-ß activation with C6D4 provides improved potency and selectivity vs general TGF-ß inhibitors for cancer immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
722 Inhibition of integrin avß8-Mediated TGF-ß activation with C6D4 provides improved potency and selectivity vs general TGF-ß inhibitors for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020105019
Dec 202012406
Jan 202162010
Feb 20213202
Mar 202160011
Apr 202150013
May 2021808
Jun 2021006
Jul 20210011
Aug 2021005
Sep 20210013
Oct 202126020
Nov 202152024
Dec 202186019
Jan 20225001
Feb 20222402
Mar 20223201
Apr 20228209
May 20228002
Jun 20226203
Jul 20229004
Aug 20227404
Sep 20227404
Oct 20228401
Nov 20229003
Dec 20227401
Jan 202311006
Feb 202311408
Mar 20235601
Apr 20234404
May 20232406
Jun 20233603
Jul 20231607
Aug 20231802
Sep 20232601
Oct 20232604
Nov 20233605
Dec 20235200
Jan 20242201
Feb 20243801
Mar 20242601
Apr 20244805
May 20243202
Jun 20244102
Jul 20242402
Aug 20242304
Sep 20245103
Oct 20245404
Nov 20242603
Dec 20242602
Jan 20252207
Feb 2025206
Apr 2025005
May 2025002
Jun 2025005
Total24140304